Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20110809007274N19Phase 3Completed
Phase 3, randomised, open-label trial of platelet-rich plasma in delayed bone healing (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Response to treatment, Duration of union and 1 more. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20110809007274N19.